Quick Answer
Arcus Biosciences, Inc. reported R&D Expense of $523.00 million for fiscal year 2025.
Arcus Biosciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $523.00M | +16.7% |
| 2024 | $448.00M | +31.8% |
| 2023 | $340.00M | +18.1% |
| 2022 | $288.00M | +12.1% |
| 2021 | $257.00M | +61.6% |
| 2020 | $159.00M | +102.6% |
| 2019 | $78.48M | +58.1% |
| 2018 | $49.65M | +5.1% |
| 2017 | $47.22M | +231.4% |
| 2016 | $14.25M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $141.00M | +14.6% | +1.4% |
| June 30, 2025 | $139.00M | +20.9% | +13.9% |
| March 31, 2025 | $122.00M | +11.9% | -0.8% |
| September 30, 2024 | $123.00M | +50.0% | +7.0% |
| June 30, 2024 | $115.00M | +36.9% | +5.5% |
| March 31, 2024 | $109.00M | +34.6% | +32.9% |
| September 30, 2023 | $82.00M | +6.5% | -2.4% |
| June 30, 2023 | $84.00M | +20.0% | +3.7% |
- Arcus Biosciences, Inc. showed an increase of +16.7% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Arcus Biosciences, Inc.’s r&d expense has grown by 3570.9% (from $14.25 million to $523.00 million).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: